超低剂量颈部CT联合低剂量对比剂用于甲状腺癌术前分期:图像质量与诊断效能
80例术前甲状腺CT患者随机分为70 kVp、60 mL对比剂组(A组,40例)与120 kVp、100 mL对比剂组(B组,40例)。两组信噪比、对比噪声比、主观图像质量、噪声及条纹伪影无显著差异,术前CT分期准确率亦无显著差异;A组有效剂量显著低于B组(0.52 ± 0.14 mSv vs 2.28 ± 0.29 mSv,p < 0.001)。
要点
- 70 kVp联合60 mL对比剂方案的有效剂量为0.52 ± 0.14 mSv,显著低于120 kVp联合100 mL方案的2.28 ± 0.29 mSv(p < 0.001)。
- 两组信噪比、对比噪声比、整体图像质量、主观噪声及条纹伪影均无显著差异(均p > 0.05)。
- 两组术前CT分期准确率无显著差异(均p > 0.05)。
核心结论
- 超低剂量70 kVp CT联合低剂量对比剂可为甲状腺癌术前分期提供足够的图像质量,且较标准120 kVp CT显著降低辐射剂量。
研究设计与样本
- 随机对照研究,共80例拟行术前甲状腺CT的患者,A组40例采用70 kVp、60 mL对比剂,B组40例采用120 kVp、100 mL对比剂;比较两组定量与定性图像质量及辐射剂量,并以病理结果为参考评价术前CT分期一致性。
关键影像表现/征象
- 两组不同解剖结构的信噪比、对比噪声比、整体图像质量、主观噪声及条纹伪影均无显著差异(均p > 0.05)。
- A组有效剂量为0.52 ± 0.14 mSv,B组为2.28 ± 0.29 mSv,A组显著低于B组(p < 0.001)。
诊断标准与关键数值
- 两组术前CT分期准确率无显著差异(均p > 0.05)。
临床应用与阅片要点
- 超低剂量70 kVp联合低剂量对比剂方案可用于甲状腺癌术前分期,图像质量与标准120 kVp方案无显著差异,且辐射剂量显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Although CT has been used as a complementary diagnostic method for the preoperative diagnosis of thyroid cancer, it has the shortcomings of substantial radiation exposure and the use of contrast material (CM). The purpose of this article is to evaluate the image quality and diagnostic performance of 70-kVp thyroid CT with low volumes of CM versus conventional 120-kVp thyroid CT protocol.
MATERIALS AND METHODS: Eighty patients referred for preoperative thyroid CT were randomly divided into two groups (group A: 40 patients, 70 kVp, 60 mL of CM; group B: 40 patients, 120 kVp, 100 mL of CM). Quantitative and qualitative image quality and radiation doses for the two groups were compared using the Mann-Whitney U and chi-square tests. Degrees of agreement between preoperative CT staging and pathologic results were evaluated and compared using the Wald statistic.
RESULTS: Calculated signal-to-noise ratios of different anatomic structures, calculated contrast-to-noise ratios, overall image quality, subjective noise, and streak artifacts were not significantly different between the two groups (all p > 0.05), and neither were the accuracies of preoperative CT staging (all p > 0.05). The estimated effective doses were significantly lower in group A (mean [± SD], 0.52 ± 0.14 mSv in group A and 2.28 ± 0.29 mSv in group B; p < 0.001).
CONCLUSION: Ultra-low-dose 70-kVp CT with a low volume of CM provides sufficient image quality for preoperative staging of thyroid cancer and substantially reduces the radiation dose compared with standard 120-kVp CT.
引用
- Yeom JA, Roh J, Jeong YJ, et al. Ultra-Low-Dose Neck CT With Low-Dose Contrast Material for Preoperative Staging of Thyroid Cancer: Image Quality and Diagnostic Performance. AJR Am J Roentgenol. 2018. PMID: 30900916. doi:10.2214/AJR.18.20334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。